Zoono Group Ltd (ASX: ZNO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Zoono Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $9.24 million
P/E Ratio 28.90
Dividend Yield 0.00%
Shares Outstanding 355.43 million
Earnings per share -0.029
Dividend per share 0.03
Year To Date Return -22.49%
Earnings Yield 3.46%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Zoono Group Ltd (ASX: ZNO)
    Latest News

    Biotechnology graphics
    Share Market News

    3 ASX biotech shares that have soared higher today

    The ASX is home to a small but vibrant and growing biotechnology sector. Here we look at 3 ASX biotech…

    Read more »

    a woman
    Coronavirus News

    How this small cap ASX biotech company is helping the fight against coronavirus

    ASX biotech company Zoono Group Ltd (ASX: ZNO) has developed a skin and surface sanitiser spray that kills coronavirus and…

    Read more »

    a woman
    Technology Shares

    Why you should add this ASX tech share to your 2020 watchlist

    The share price of ASX software company Objective Corporation Limited (ASX:OCL) has rallied 30% over the past few weeks. Here’s…

    Read more »

    a woman
    Coronavirus News

    Coronavirus: Why this small cap ASX biotech share jumped 12% higher

    The Zoono Group Ltd (ASX:ZNO) share price jumped 125 higher on Wednesday. Here's why the biotech share is benefiting from…

    Read more »

    a woman
    Share Market News

    Here's why the Zoono share price zoomed 13% higher today

    The Zoono Group Ltd (ASX: ZNO) share price is soaring higher today after a business update on its performance so…

    Read more »

    a woman
    Share Market News

    Why this small-cap ASX healthcare share surged 24% today

    The Eagle Health Holdings Ltd (ASX:EHH) share price opened 24.32% higher today on news it is expanding production of disposable medical…

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    Share Market News

    Why the Zoono share price has skyrocketed 250% in 2020

    Zoono Group Limited (ASX: ZNO) has become an unlikely leader in the global fight against the spread of coronavirus.

    Read more »

    a woman
    Share Market News

    Why the Zoono share price rocketed another 19% higher today

    Here's why the Zoono Group Ltd (ASX: ZNO) share price has rocketed another 19.26% today to close at $2.26.

    Read more »

    a woman
    Share Gainers

    Why Amaysim, Freedom Foods, NEXTDC, & Zoono are pushing higher

    NEXTDC Ltd (ASX:NXT) and Zoono Group Ltd (ASX:ZNO) shares are two of four defying the market selloff and pushing higher…

    Read more »

    a woman
    Coronavirus News

    Zoono share price rockets 28% on coronavirus test results

    The Zoono Group Ltd (ASX:ZNO) share price is rocketing higher after the company announced successful test results against the coronavirus.

    Read more »

    a woman
    Share Market News

    These 3 ASX healthcare shares could make you rich

    Here are 3 ASX healthcare shares looking to carve out their own niches – and in doing so, might even…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2020 $0.0300 0.00% Final 21 Sep 2020

    ZNO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Zoono Group Ltd

    Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products, and mold remediation treatments. Geographically, it derives a majority of its revenue from Australasia, Asia, the United States, and India, and also has a presence in the United Kingdom and Europe.

    ZNO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    15 Nov 2024 $0.03 $0.00 0.00% 21,324 $0.03 $0.03 $0.03
    14 Nov 2024 $0.03 $0.00 0.00% 6,135 $0.03 $0.03 $0.03
    13 Nov 2024 $0.03 $0.00 0.00% 219,590 $0.03 $0.03 $0.03
    12 Nov 2024 $0.03 $0.00 0.00% 428,274 $0.03 $0.03 $0.03
    08 Nov 2024 $0.03 $0.00 0.00% 2,653 $0.03 $0.03 $0.03
    07 Nov 2024 $0.03 $0.00 0.00% 37,423 $0.03 $0.03 $0.03
    06 Nov 2024 $0.03 $0.00 0.00% 38,922 $0.03 $0.03 $0.03
    05 Nov 2024 $0.03 $0.00 0.00% 238,773 $0.03 $0.03 $0.03
    04 Nov 2024 $0.03 $0.00 0.00% 478,763 $0.03 $0.03 $0.03
    01 Nov 2024 $0.03 $0.00 0.00% 237,133 $0.03 $0.03 $0.03
    31 Oct 2024 $0.03 $0.00 0.00% 263,322 $0.03 $0.03 $0.03
    30 Oct 2024 $0.03 $0.00 0.00% 188,107 $0.03 $0.03 $0.03
    28 Oct 2024 $0.03 $0.00 0.00% 7,245 $0.03 $0.03 $0.03
    25 Oct 2024 $0.03 $0.00 0.00% 57,010 $0.03 $0.03 $0.03
    24 Oct 2024 $0.03 $0.00 0.00% 50,017 $0.03 $0.03 $0.03
    23 Oct 2024 $0.03 $0.00 0.00% 105,000 $0.03 $0.03 $0.03
    22 Oct 2024 $0.03 $0.00 0.00% 10,000 $0.03 $0.03 $0.03
    21 Oct 2024 $0.03 $0.00 0.00% 856,856 $0.03 $0.03 $0.03
    18 Oct 2024 $0.03 $0.00 0.00% 348,852 $0.03 $0.03 $0.03

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    10 May 2024 Donald Clarke Issued 168,750 $4,556
    Rights issue.
    10 May 2024 Elissa Hansen Issued 166,875 $4,505
    Rights issue.
    10 May 2024 Paul Hyslop Issued 30,000,000 $810,000
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Donald Ian Clarke Non-Executive Director Apr 2017
    Mr Clarke was a Partner of Minter Ellison's Melbourne Corporate Group, from 1988- 2015. He currently acts as a consultant to them. Don has advised corporate clients on corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He is able to draw on his first-hand experience as a corporate lawyer and a Director, of Directors' duties and responsibilities and best practice corporate governance, when advising on the legal and practical issues faced at head office and board level. He is chair of Risk Committee. Directorships of other listed companies in the past three years - Non-Executive Director, Webjet Limited (appointed January 2008).
    Ms Elissa Hansen Company SecretaryNon Executive Director Aug 2015
    Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She brings best practice governance advice, ensuring compliance with the Listing Rules, Corporations Act and other relevant legislation. She is member of the Risk Committee. Directorships of other listed companies in the past three years - Non-Executive Director, QMines Limited (appointed August 2020); Non-executive Director, Aeeris Limited (appointed May 2022).
    Mr Paul Hyslop Managing Director Apr 2017
    Mr Hyslop, prior to establishing Zoono, was involved in several entrepreneurial ventures ranging from the establishment of a successful private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002 - 2005. Extremely adept at dealing with businesses and consumers alike, he co-established the Business Brokerage Division at Bayley's Real Estate - one of the real estate and business brokerages in New Zealand. Paul's experience in business development dates back to the 1970s, when he started a personal-care services business after high school, grew it into eight locations and later sold it to his employees. He has also been a commercial flying instructor and Airline pilot, having flown commuter planes for Eagle Air, owned by Air New Zealand.
    Mr Barry Woolcott Global General ManagerChief Executive Officer Mar 2022
    -
    Paul Ravlich Chief Financial Officer
    -
    Lew MacKinnon Chief Operating Officer
    -
    Barry Woolcott Global General ManagerChief Executive Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Paul Russell Hyslop & Margaret Jane Morgan & Npt Meg Trustee Limited <Meg A/C> 104,447,500 29.57%
    BNP Paribas Noms Pty Ltd 36,335,278 10.29%
    Citicorp Nominees Pty Limited 23,217,468 6.57%
    Mr Eelco Wiersma 17,493,204 4.95%
    UBS nominees Pty Ltd 10,141,649 2.87%
    Stephen Henesy 6,214,286 1.76%
    Yasin Shariff 6,214,286 1.76%
    Marissa Tacy Muirhead 4,118,889 1.17%
    Mr Theophilos Papantoniou 4,100,000 1.16%
    Lewis Andrew Craig Mackinnon 3,867,131 1.09%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 3,600,000 1.02%
    Lordmax Pty Ltd <Al Fund A/C> 3,000,000 0.85%
    Ms Marie Tania Genn 2,873,585 0.81%
    Pw And Vj Cooper Pty Limited <P W & V J Cooper S/F A/C> 2,592,592 0.73%
    Mr Andrew Moffa & Mrs Sonia Moffa <The Moffa Superfund A/C> 2,592,592 0.73%
    Loosemore Investments Pty Ltd <Loosemore Invest Family A/C> 2,222,222 0.63%
    Mrs Catherine Anne Marson & Mr Joseph Marson <The Marson Family S/F A/C> 2,222,222 0.63%
    Mr Ronald Duje Vela 1,951,852 0.55%
    Woolcott Investments Limited <The Woolcott Investment A/C> 1,886,792 0.53%
    Sargram Investments Pty Ltd <Sargram Super A/C> 1,851,852 0.52%

    Profile

    since

    Note